Key Insights

Highlights

Treatment Research

1 treatments under study, led by Mutation Burden Cfmb Analysis

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting2
Active Not Recruiting1
Enrolling By Invitation1

Clinical Trials (4)

Showing 4 of 4 trials
NCT05350761Recruiting

Rare Tumors and Cancer Predisposition in Individuals and Families

NCT00001163Active Not Recruiting

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

NCT06792721Recruiting

MEASUREMENT OF CIRCULATING MUTATION BURDEN

NCT06800599Enrolling By InvitationPrimary

Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment

Showing all 4 trials

Research Network

Common Treatments

  • Mutation Burden Cfmb Analysis1

Active Sponsors

  • National Cancer Institute (NCI)2
  • Centre Francois Baclesse1
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna1

Top Investigators

Related Conditions

  • Cancer2
  • Environment2
  • Hereditary Neoplasms2
  • Mutation Burden1
  • Breast Carcinoma1

Activity Timeline